.svg)
ZIM Laboratories Limited and Globalpharma Co. (L.L.C.) Announce Strategic Collaboration to Commercialize Oral Thin Film Products in the GCC Region
ZIM Laboratories Limited Receives Marketing Authorization (MA) for Dimethyl Fumarate (120 mg & 240 mg) Modified Release Capsules in Portugal, Europe
ZIM Laboratories Limited and Neuraxpharm Announce Grant of Marketing Authorization for Buprenorphine Sublingual Film in Europe.
ViewZIM Laboratories Limited Announces Grant of Marketing Authorization for Azithromycin for Oral Suspension 200 mg/5ml (40 mg/ml) in Portugal, Europe.
ZIM Laboratories Limited has been granted marketing authorization for Sildenafil 50 mg ODS by AEMPS.
